Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities:    
Net income (loss) attributable to MariMed Inc. $ (18,445,529) $ 122,309
Net income (loss) attributable to noncontrolling interests 223,882 177,852
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation 445,504 263,624
Amortization of stock option and warrant issuances 14,973,270 293,519
Common stock issued for services 3,640,621 38,965
Loss on preferred stock conversions 34,044
Loss on debt settlements 4,184,631 482,133
Changes in operating assets and liabilities:    
Accounts receivable, net (2,566,254) (793,081)
Deferred rents receivable (1,096,908) (71,887)
Due from third parties (1,925,735) (467,583)
Due from related parties 52,727
Other current assets (100,684) (66,422)
Other assets 29,731 (169,990)
Accounts payable (198,836) 3,069,948
Accrued expenses 129,689 (22,495)
Due to related parties (196,000) (53,342)
Deferred revenue (226,950)
Other liabilities 53,755 500
Net cash provided by (used in) operating activities (1,736,100) 2,629,827
Cash flows from investing activities:    
Purchase of property and equipment (7,259,413) (11,502,688)
Investment in debentures and notes (7,050,000)
Investment in Sprout (100,000)
Interest on notes receivable 29,087 29,625
Net cash used in investing activities (14,375,756) (11,473,063)
Cash flows from financing activities:    
Proceeds from subscribed preferred stock 200,000
Issuance of common stock 16,896,000 5,150,000
Issuance (repayments) of promissory notes, net 2,300,000 3,650,000
Proceeds from (payments of) mortgages payable, net 1,913,408 (80,622)
Exercise of stock options 39,000 7,500
Exercise of warrants 212,284
Distributions (507,453)
Net cash provided by financing activities 20,853,239 8,926,878
Net change to cash and cash equivalents 4,736,813 83,642
Cash and cash equivalents at beginning of period 1,290,231 569,356
Cash and cash equivalents at end of period 6,027,044 652,998
Supplemental disclosure of cash flow information:    
Cash paid for interest 931,195 418,738
Cash paid for taxes 12,021 8,138
Non-cash activities:    
Equity issued to settle debt 8,425,000 2,050,000
Equity issued for acquisitions $ 600,000 $ 370,000